These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6291347)

  • 1. The effects of clofibrate ingestion on alveolar macrophage peroxisome content and oxygen metabolism.
    Drath DB; Davies P; Shorrey JM; Simpson P
    Agents Actions; 1982 Jul; 12(3):365-70. PubMed ID: 6291347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clofibrate increases the number of peroxisomes and of lamellar bodies in alveolar cells type II of the rat lung.
    Fringes B; Gorgas K; Reith A
    Eur J Cell Biol; 1988 Apr; 46(1):136-43. PubMed ID: 3260863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification of surfactant metabolizing cells in rat lung by clofibrate, a hypolipidemic peroxisome proliferating agent. Evidence to suggest that clofibrate influences pulmonary surfactant metabolism.
    Fringes B; Gorgas K; Reith A
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1988; 54(4):232-40. PubMed ID: 2895534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two hypolipidemic peroxisome proliferators increase the number of lamellar bodies in alveolar cells type II of the rat lung.
    Fringes B; Reith A
    Exp Mol Pathol; 1988 Apr; 48(2):262-71. PubMed ID: 3258252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polydispersity of rat liver peroxisomes induced by the hypolipidemic and carcinogenic agent clofibrate.
    Flatmark T; Christiansen EN; Kryvi H
    Eur J Cell Biol; 1981 Apr; 24(1):62-9. PubMed ID: 7238535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of acute inflammatory lung injury on the respiratory burst and protein kinase C activity of rat pulmonary alveolar macrophages.
    Brieland JK; Balazovich K; Fantone JC
    Am Rev Respir Dis; 1989 Feb; 139(2):378-81. PubMed ID: 2536527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of phorbol myristate acetate on the metabolism and ultrastructure of human alveolar macrophages.
    Hoidal JR; Repine JE; Beall GD; Rasp FL; White JG
    Am J Pathol; 1978 Jun; 91(3):469-82. PubMed ID: 207188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response of microbodies in Morris hepatoma 9618A to clofibrate.
    Tsukada H; Mochizuki Y; Itabashi M; Gotoh M; Morris HP
    J Natl Cancer Inst; 1975 Jul; 55(1):153-8. PubMed ID: 169361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Peroxisomes and hypolipidemic agents ].
    Heller F; Pourbaix S
    Sem Hop; 1982 Jul; 58(28-29):1712-7. PubMed ID: 6289453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biosynthesis of methylguanidine in the hepatic peroxisomes and the effect of the induction of peroxisomal enzymes by clofibrate.
    Takemura K; Aoyagi K; Nagase S; Gotoh M; Hirayama A; Ueda A; Tomida C; Koyama A
    Nephron; 1998; 78(1):82-7. PubMed ID: 9453408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iprindole-induced phospholipidosis in rat alveolar macrophages: alterations in oxygen consumption and release of oxidants.
    McNulty MJ; Reasor MJ
    Exp Lung Res; 1981 Mar; 2(1):57-69. PubMed ID: 6286298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response of microperoxisomes in rat small intestinal mucosa to CPIB, a hypolipidemic drug.
    Svoboda DJ
    Biochem Pharmacol; 1976 Dec; 25(24):2750-2. PubMed ID: 1008899
    [No Abstract]   [Full Text] [Related]  

  • 13. Structure, composition, physical properties, and turnover of proliferated peroxisomes. A study of the trophic effects of Su-13437 on rat liver.
    Leighton F; Coloma L; Koenig C
    J Cell Biol; 1975 Nov; 67(2PT.1):281-309. PubMed ID: 406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of an NAD(P)H oxidase-like enzyme in superoxide anion and hydrogen peroxide generation by rat type II cells.
    van Klaveren RJ; Roelant C; Boogaerts M; Demedts M; Nemery B
    Thorax; 1997 May; 52(5):465-71. PubMed ID: 9176540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic peroxisome proliferation: induction by two novel compounds structurally unrelated to clofibrate.
    Reddy JK; Krishnakantha TP
    Science; 1975 Nov; 190(4216):787-9. PubMed ID: 1198095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of clofibrate and ethyl-5-(p-chlorophenoxy)-3-hydroxy-3-methylpentanoate induced changes in serum lipoprotein cholesterol and hepatic peroxisome proliferation in the normal rat.
    Stevens TJ; Stafford WW; Day CE; Block EM
    Artery; 1983; 12(2):81-94. PubMed ID: 6678582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible properties of microbodies (peroxisomes). Microbody proliferation and hypolipidemic drugs.
    Reddy JK
    J Histochem Cytochem; 1973 Nov; 21(11):967-71. PubMed ID: 4587529
    [No Abstract]   [Full Text] [Related]  

  • 18. Induction of peroxisomal enzymes and a 64-kDa peptide in cultured mouse macrophages treated with clofibrate.
    Couve AO; Koenig C; Santos MJ
    Exp Cell Res; 1992 Oct; 202(2):541-4. PubMed ID: 1397105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A fatty acyl-CoA oxidizing system in rat liver peroxisomes; enhancement by clofibrate, a hypolipidemic drug.
    Lazarow PB; De Duve C
    Proc Natl Acad Sci U S A; 1976 Jun; 73(6):2043-6. PubMed ID: 180535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A characteristic membrane protein of liver peroxisomes inducible by clofibrate.
    Hüttinger M; Goldenberg H; Kramar R
    Biochim Biophys Acta; 1979 Dec; 558(2):251-4. PubMed ID: 508747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.